441 related articles for article (PubMed ID: 28749773)
21. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
22. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
[TBL] [Abstract][Full Text] [Related]
23. Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.
Kalnoky M; Bancone G; Kahn M; Chu CS; Chowwiwat N; Wilaisrisak P; Pal S; LaRue N; Leader B; Nosten F; Domingo GJ
Eur J Haematol; 2018 Mar; 100(3):294-303. PubMed ID: 29240263
[TBL] [Abstract][Full Text] [Related]
24. Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Deng Z; Yang F; Bai Y; He L; Li Q; Wu Y; Luo L; Li H; Ma L; Yang Z; He Y; Cui L
PLoS One; 2017; 12(5):e0177917. PubMed ID: 28531196
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
26. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
[TBL] [Abstract][Full Text] [Related]
28. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
29. The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.
Bancone G; Kalnoky M; Chu CS; Chowwiwat N; Kahn M; Malleret B; Wilaisrisak P; Rénia L; Domingo GJ; Nosten F
Sci Rep; 2017 Aug; 7(1):9822. PubMed ID: 28852037
[TBL] [Abstract][Full Text] [Related]
30. Approval of Tafenoquine for Malaria Chemoprophylaxis.
Berman JD
Am J Trop Med Hyg; 2019 Jun; 100(6):1301-1304. PubMed ID: 30887947
[TBL] [Abstract][Full Text] [Related]
31. Tafenoquine: a toxicity overview.
Chu CS; Hwang J
Expert Opin Drug Saf; 2021 Mar; 20(3):349-362. PubMed ID: 33306921
[No Abstract] [Full Text] [Related]
32. Haematological profile of malaria patients with G6PD and PKLR variants (erythrocytic enzymopathies): a cross-sectional study in Thailand.
Mungkalasut P; Kiatamornrak P; Jugnam-Ang W; Krudsood S; Cheepsunthorn P; Cheepsunthorn CL
Malar J; 2022 Aug; 21(1):250. PubMed ID: 36038921
[TBL] [Abstract][Full Text] [Related]
33. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
34. Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study).
Santos A; Brito M; Silva E; Rocha F; Oliveira A; Dávila R; Gama H; Albuquerque J; Paiva M; Baía-Silva D; Sampaio V; Balieiro P; Rufatto R; Grewal Daumerie P; Peterka C; Edilson Lima F; Monteiro W; Arcanjo A; Silva R; Batista Pereira D; Lacerda M; Murta F
PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012197. PubMed ID: 38837977
[TBL] [Abstract][Full Text] [Related]
35. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
Commons RJ; McCarthy JS; Price RN
Med J Aust; 2020 Mar; 212(4):152-153.e1. PubMed ID: 32036613
[No Abstract] [Full Text] [Related]
36. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
[TBL] [Abstract][Full Text] [Related]
37. Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.
Uthman OA; Graves PM; Saunders R; Gelband H; Richardson M; Garner P
Malar J; 2017 Aug; 16(1):346. PubMed ID: 28830424
[TBL] [Abstract][Full Text] [Related]
38. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
[TBL] [Abstract][Full Text] [Related]
39. Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
Calvaresi EC; Genzen JR
Am J Clin Pathol; 2020 Jul; 154(2):248-254. PubMed ID: 32405645
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
